Table of Contents
Volume 8 | Issue 2
Publication Date: September 2006- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
84 |
Therapy for Stage III Non–Small-Cell Lung Cancer: Bob Beamon or Chemo-Beamo? Walter J. Curran, Jr |
|
Meeting Highlights | ||
88-92 |
Highlights From: 7th International Lung Cancer Congress Workshop; Maui, HI; June 28-July 1, 2006 Aarati Ranganathan, David Lee, Corey Langer, Ken Yoneda, David R. Gandara |
|
Mini-Review | ||
93-98 |
Aurora Kinase Inhibitors: A New Class of Targeted Drugs in Cancer Oliver Gautschi, Philip C. Mack, Angela M. Davies, Primo N. Lara, Jr, David R. Gandara |
|
Comprehensive Reviews | ||
99-109 |
Future Trends in Patient-Reported Outcomes Assessment for Patients with Advanced-Stage Lung Cancer Receiving Targeted Therapy David T. Eton, Kathleen J. Yost, David Cella |
|
110-115 |
Evolving Role of Interventional Pulmonology in the Interdisciplinary Approach to the Staging and Management of Lung Cancer: Bronchoscopic Mediastinal Staging of Lung Cancer Stefano Gasparini |
|
Original Contributions | ||
116-121 |
Long-Term Survival with Concurrent Chemoradiation Therapy Followed by Consolidation Docetaxel in Stage IIIB Non–Small-Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S9504) David R. Gandara, Kari Chansky, Kathy S. Albain, Laurie E. Gaspar, Primo N. Lara, Jr, Karen Kelly, John Crowley, Robert Livingston |
|
122-129 |
Phase II Trial of Sequential Chemotherapy Followed by Chemoradiation, Surgery, and Postoperative Chemotherapy for the Treatment of Stage IIIA/IIIB Non–Small-Cell Lung Cancer Prudence Lam, Stuart Berman, Robert Thurer, Simon Ashiku, Malcolm DeCamp, Michael Goldstein, Susan Schumer, Balazs Halmos, Daniel Karp, Danielle Coute, Mark Bergman, Cynthia Boyd-Sirard, Sai-Hong Ou, Alona Muzikansky, Cally Woodard, Mark Huberman |
|
130-134 |
Topotecan Therapy in Patients with Relapsed Small-Cell Lung Cancer and Poor Performance Status Rogerio C. Lilenbaum, Rudolf M. Huber, Joseph Treat, Gregory Masters, Sabine Kaubitzsch, Stephen Lane, Paul Wissel |
|
135-139 |
Randomized, Multicenter, Open-Label Phase II Study of Gemcitabine plus Single-Dose Versus Split-Dose Carboplatin in the Treatment of Patients with Advanced-Stage Non–Small-Cell Lung Cancer Wolfgang Schuette, Thomas Blankenburg, Claus-Peter Schneider, Ludwig Fischer von Weikersthal, Sylvia Guetz, Gerhard Laier-Groeneveld, Johann Christian Virchow, Assnad Chemaissani, Martin Reck |
|
140-145 |
Cell-Free DNA Concentration in Pleural Fluid and Serum: Quantitative Approach and Potential Prognostic Factor in Patients with Cancer and Pleural Effusions Susana Benlloch, Juan Luis Martí-Ciriquián, José Marcelo Galbis-Caravajal, Concepción Martín, José Sánchez-Payá, José Manuel Rodríguez-Paniagua, Santiago Romero, Bartomeu Massutí |
|
Case Report | ||
146-148 |
A Multidisciplinary Approach to Management in a Patient with Bilateral Superior Sulcus Non–Small-Cell Lung Carcinoma Millie S. Roy, Quynh-Thu Le, Jessica S. Donington, Heather A. Wakelee |
|
Clinical Trials | ||
149 |
Selected Clinical Trials in Lung Cancer CIG Media Group |
|